Horsham, PA (PRWEB) August 17, 2012
DIA, the premier global association dedicated to knowledge exchange that fosters innovation to raise the level of health and well-being worldwide, will co-host the DIA/FDA Biosimilars Conference: Guidances, Science, and BsUFA from September 12-13 in Washington, DC.
This conference will explore FDA’s plans to implement BsUFA to review the future path for patients and doctors as potentially interchangeable biologics are coming forth in the market, and classify the challenges associated with demonstrations of biosimilarity.
Featured topics will include:
DIA (http://www.diahome.org) is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices and related medical products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; and Beijing, China. Stay updated on hot topic news at #druginfoassn on Twitter. Follow DIA on FaceBook, Twitter, LinkedIn, and YouTube.